stockrowCelldex Therapeutics, Inc. (CLDX) vs Septerna, Inc. (SEPN)
- Celldex Therapeutics, Inc. CLDX 29.90 +5.77%
- Septerna, Inc. SEPN 48.95 +3.38%
Celldex Therapeutics, Inc. and Septerna, Inc. are both Biotechnology companies. Celldex Therapeutics, Inc. and Septerna, Inc. are of similar size ($2.2B and $2.2B). Septerna, Inc. grew revenue faster over the last twelve months: 13,520.1% against −88.3%. Septerna, Inc. has the higher net margin (−24.5% vs −33,883.8%) and the lower return on invested capital (−189.0% vs 0.00%). Across the 16 metrics below, Septerna, Inc. leads on 12 and Celldex Therapeutics, Inc. on 4.
Valuation
Profitability
| Metric | CLDX | SEPN | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 68.51% |
| Operating margin | (36,733.82%) | (44.04%) | 0.00% |
| Net margin | (33,883.77%) | (24.51%) | 0.00% |
| Free cash flow margin | (27,294.81%) | 118.93% | 0.00% |
| Return on equity | (43.88%) | (6.34%) | (51.96%) |
| Return on assets | (40.76%) | (4.94%) | (46.06%) |
| Return on invested capital | 0.00% | (189.01%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack